Table 3.

Estimated list price for approved treatment and therapeutic products in recurrent CDIs.

Product	Indication in recurrent CDIa	Estimated List Price (in US Dollars)b
Vowst	Therapeutic	17,500 USD for 12 capsules
Rebyota	Therapeutic	9000 to 10,000 USD for a single 150 mL dose
Dificid (fidaxomicin)	Treatment	4000 to 7000 USD for 20 200mg pills
Vancomycin	Treatment	1000 to 2000 USD for 40 125mg capsules
Probiotics	Therapeutic	100–200 USD for 21 days
Bezlotoxumab	Therapeutic/Treatment	4000 to 5000 USD for 40 mL 25mg/mL IV solution

^aTherapeutic signifies that the product is used to prevent recurrent CDI episodes and not for curative treatment. Treatment signifies that the product is used for curative treatment of recurrent CDI episodes. Recurrent CDI episode is defined as ≥ 3 CDI episodes within the last 1 year including the presenting episode.

^bEstimated list prices were taken either from websites of online sellers/pharmacies or from the manufacturer’s official website. Prices may differ between regions.